Negative regulation of myeloid leukocyte mediated immunity

pathway activity — cross-omics
GO:0002887Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of myeloid leukocyte mediated immunity pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are COQ3, FANCL, and CD22, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of myeloid leukocyte mediated immunity activity versus COQ3 in LSCC (Pearson r = -0.15).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCCOQ3 →-0.579-0.349<.001.00434
LSCCFANCL →-0.725-0.374<.001.00434
LUADCD22 →+0.463+0.580<.001<.00134
LSCCE2F6 →-0.714-0.436<.001.00334
LSCCHMGB1 →-0.463-0.442<.001.00534
UCECCXCL2 →+1.066+0.561.003.00433
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0002887 vs COQ3 — LSCC

Per-sample scatter of Negative regulation of myeloid leukocyte mediated immunity activity vs COQ3 in LSCC.

Explore this scatter interactively →

Exploration